Docs
🇬🇧
en
Mint Work
Sign in
Get Started
By
Faculty Opinions recommendation of Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma | NobleID
v1
Faculty Opinions recommendation of Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
Otto Hemminki
OH
Otto Hemminki
NobleID
NI5P89W82R02S13
Type:
Journal Article
Claim Your Authorship
Cite
Sign in to see the full record
Creating an account is free.
Sign in
Create an account
For data access, contact
info@nobleid.org
.
